As of now, their focus is on Human Immunodeficiency Virus (HIV) anti-infectives, such as Bevirimat.
Torrent Pharmaceuticals | Emcure Pharmaceuticals | Barr Pharmaceuticals | Valeant Pharmaceuticals | Reata Pharmaceuticals | Millennium Pharmaceuticals | Anthera Pharmaceuticals | Quark Pharmaceuticals | Norwich Pharmaceuticals | Incepta Pharmaceuticals | Glenmark Pharmaceuticals |